228 related articles for article (PubMed ID: 12069375)
1. The impact of thrombopoietin on clinical practice.
Basser R
Curr Pharm Des; 2002; 8(5):369-77. PubMed ID: 12069375
[TBL] [Abstract][Full Text] [Related]
2. Clinical biology and potential use of thrombopoietin.
Basser R
Can J Gastroenterol; 2000 Nov; 14 Suppl D():73D-78D. PubMed ID: 11110616
[TBL] [Abstract][Full Text] [Related]
3. Cytokines for the treatment of thrombocytopenia.
Ciurea SO; Hoffman R
Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
[TBL] [Abstract][Full Text] [Related]
4. Use of thrombopoietic growth factors in acute leukemia.
Kaushansky K
Leukemia; 2000 Mar; 14(3):505-8. PubMed ID: 10720151
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.
Kuter DJ; Begley CG
Blood; 2002 Nov; 100(10):3457-69. PubMed ID: 12411315
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions.
Haznedaroglu IC; Goker H; Turgut M; Buyukasik Y; Benekli M
Clin Appl Thromb Hemost; 2002 Jul; 8(3):193-212. PubMed ID: 12361196
[TBL] [Abstract][Full Text] [Related]
7. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human thrombopoietin: clinical experience and in vivo biology.
Vadhan-Raj S
Semin Hematol; 1998 Jul; 35(3):261-8. PubMed ID: 9685172
[TBL] [Abstract][Full Text] [Related]
10. New thrombopoietic growth factors.
Kuter DJ
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S347-56. PubMed ID: 19778863
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia.
Vadhan-Raj S
Semin Hematol; 2000 Apr; 37(2 Suppl 4):28-34. PubMed ID: 10831286
[TBL] [Abstract][Full Text] [Related]
12. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
Hassan HT; Zander AR
J Hematother; 1996 Aug; 5(4):407-14. PubMed ID: 8877716
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation.
Weisdorf DJ; DeFor T; Nichol J; Panoskaltsis-Mortari A; Blazar BR
Bone Marrow Transplant; 2000 Apr; 25(7):711-5. PubMed ID: 10745255
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
[TBL] [Abstract][Full Text] [Related]
16. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents.
Vadhan-Raj S
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S26-32. PubMed ID: 19245931
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic potential of thrombopoietin].
Geissler K
Wien Klin Wochenschr; 2000 Oct; 112(19):829-34. PubMed ID: 11098533
[TBL] [Abstract][Full Text] [Related]
18. Clinical approaches involving thrombopoietin to shorten the period of thrombocytopenia after high-dose chemotherapy.
Tijssen MR; van der Schoot CE; Voermans C; Zwaginga JJ
Transfus Med Rev; 2006 Oct; 20(4):283-93. PubMed ID: 17008166
[TBL] [Abstract][Full Text] [Related]
19. [Consensus on the clinical diagnosis, treatment and prevention of cancer treatment-induced thrombocytopenia in China (2023 edition)].
;
Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(33):2579-2590. PubMed ID: 37650204
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Vadhan-Raj S; Verschraegen CF; Bueso-Ramos C; Broxmeyer HE; Kudelkà AP; Freedman RS; Edwards CL; Gershenson D; Jones D; Ashby M; Kavanagh JJ
Ann Intern Med; 2000 Mar; 132(5):364-8. PubMed ID: 10691586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
